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Abstract
Micronutrient deficiencies are prevalent among Zimbabweans with serious health and social implications. Due to a
lack of a national micronutrient food fortification policy, the Zimbabwe Ministry of Health and Child Care
established a policy for the prevention of maternal micronutrient deficiencies, which centres on pregnant women
receiving daily iron and folic acid (IFA) at their first antenatal care visit and throughout pregnancy. Despite these
efforts, utilization of IFA supplementation in pregnancy in Zimbabwe is low. This study aimed to understand the
experiences and knowledge of IFA supplementation among pregnant women and healthcare workers in Harare,
Zimbabwe, and the influence of health-service and social environments on utilization. Semi-structured in-depth
interviews were conducted in Shona and English, with pregnant women (n=24) and healthcare workers (n=14)
providing direct antenatal care services to pregnant women in two high-density community clinics. Data were
analysed thematically using NVivo 10. Influences on utilization were at the individual and structural environmental
levels. Reasons for low utilization of IFA supplementation included forgetting to take IFA, side effects, misconcep-
tions about IFA, limited access to nutrition information, delayed entry or non-uptake of antenatal care and social
norms of pregnant women for IFA supplementation. Utilization was enhanced by knowledge of risks and benefits
of supplementation, fear of negative health complications with non-utilization, family support and healthcare
worker recommendation for supplementation. Study findings can inform approaches to strengthen micronutrient
supplementation utilization to improve the micronutrient status of pregnant women to decrease maternal mortality
and improve overall maternal and child health in Zimbabwe. © 2016 John Wiley & Sons Ltd
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tion in pregnancy, antenatal care, Zimbabwe.
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Introduction
Globally, the prevalence of anaemia in pregnant
women is 38% (32.4 million) with half due to iron defi-
ciency (WHO 2014). Maternal anaemia, defined as low
concentrations of haemoglobin, is associated with ma-
ternal and child morbidity and mortality with increased
risk of post-partum haemorrhage, miscarriages, still-
births, prematurity and low birthweight (Levy et al.
2005; WHO 2011;WHO 2014). Micronutrient deficien-
cies are prevalent in Zimbabwe with serious health and
social implications, particularly among pregnant
women who have an increased nutritional need
(Montgomery 2003). Iron deficiency, the most common
cause of anaemia globally, is the most prevalent micro-
nutrient deficiency among pregnant women, with
32.4% of pregnant women having anaemia, which con-
tributes to the country’s high maternal mortality ratio
of 581 deaths per 100 000 live births (WHO 2011;
ZIMSTAT 2015).
Micronutrient deficiencies persist in developing
countries like Zimbabwe because of food insecurity
and lack of national policy concerning fortification of
foods with micronutrients (Gadaga et al. 2009;
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Darnton-Hill 2012). Given this, the Ministry of Health
and Child Care of Zimbabwe established a national
policy at independence in 1980 for preventing maternal
micronutrient deficiencies that centres on pregnant
women receiving daily iron and folic acid (IFA) supple-
ments at their first antenatal care (ANC) visit (at 8–
16weeks pregnant) and throughout pregnancy (WHO
2012; ZDHS 2012; MOHCC 2015).
The recommended IFA composition includes 30–
60mg of elemental iron and 400μg (0.4mg) of folic acid
(WHO 2012). Folic acid reduces risks of adverse preg-
nancy outcomes such as fetal malformations, impaired
fetal growth, pre-term delivery and maternal anaemia
and is included with iron to meet increased require-
ments during pregnancy (Tamura & Picciano 2006;
Fekete et al. 2010; Peña-Rosas et al. 2012; WHO
2012). Iron supplementation improves iron status dur-
ing pregnancy and prevents risks associated with iron
deficiency and maternal anaemia (Allen 2000; Peña-
Rosas et al. 2012; Nisar &Dibley 2014). Benefits of iron
supplementation extend to infants with an increase in
birth length and higher ferritin levels at 3–6months
(Peña-Rosas et al. 2012). IFA supplementation is more
effective when taken in the periconceptional period
and throughout pregnancy with reductions in maternal
anaemia, stunting in children under 2 years old, low
birthweight, and neonatal and under 5 mortality
(Fekete et al. 2010; Imdad & Bhutta 2012; Bhutta et al.
2013; Nisar et al. 2015; Nisar et al. 2016). Countries with
successful policies for IFA supplementation in preg-
nancy integrate IFA supplementation with ANC and
community outreach (Mora 2007; Sanghvi et al. 2010).
The 2010–2011 Zimbabwe Demographic and Health
Survey (ZDHS) highlights that utilization of IFA sup-
plementation among pregnant women is low, with
49.8% of women not taking iron supplements during
their last pregnancy and 36.5% taking it for less than
60days. Factors that contribute to consumption such
as requests by patients, distribution by healthcare
workers, and availability of supply were not assessed
in the 2010–2011 ZDHS. In addition, the 2010–2011
ZDHS did not provide qualitative data to explain low
IFA utilization rates, and there are no documented
studies explaining low utilization of IFA supplementa-
tion in Zimbabwe. This research aimed to understand
individual experiences with and knowledge about IFA
supplementation of pregnant women and healthcare
workers in Harare, Zimbabwe, the health-service and
social environment in which IFA supplementation oc-
curs, and how these influence utilization of IFA
supplementation.
Methods
Setting
Zimbabwe is in south-east Africa and has a popula-
tion of 12 973 808 with 6 234 931 men and 6 738 877
women (ZIMSTAT 2013). English and Shona are
the official and predominant languages, respec-
tively. The study was conducted in two
municipality-owed clinics in two low-income high-
density communities in the capital city Harare.
Mbare has a population of 86 019 and is in southern
Key messages
• Reasons for low utilization of iron and folic acid (IFA) supplementation were forgetting to take IFA, side effects,
misconceptions about IFA supplementation, limited access to nutrition information, delayed entry or non-uptake
of antenatal care services, and social norms of pregnant women for IFA supplementation.
• Utilization of IFA supplementation was enhanced by knowledge of risks and benefits of supplementation, fear of
negative health complications with non-utilization, family support, and healthcare provider recommendation.
• Future approaches to improve maternal IFA supplementation utilization in Zimbabwe should address individual and
structural environmental factors that begin before pregnancy and continue throughout pregnancy. These include
reaching pregnant women who are currently not seeking antenatal care services and continuing to ensure supplies
of the full regimen of IFA are available, not just for women using antenatal care, but for all pregnant women in clinic
catchment areas.
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Harare, while Mabvuku has a population of 47 154
and is in eastern Harare (City of Harare 2014).
The study clinics were selected because they served
similar low-income high-density communities to
garner diverse perspectives on IFA utilization when
compared with including one study clinic and be-
cause they had the highest number of deliveries of
any municipality-owed clinics in the city (City of
Harare 2014).
Study design
We used a qualitative research design with semi-
structured in-depth interviews. The study sample in-
cluded a purposive sample of: (1) 24 pregnant women
aged 18 years and older who had attended at least one
ANC visit during their current pregnancy and resided
in either of the two study communities, and (2) 14
healthcare workers employed by either of the two study
clinics and who provided direct counselling and
healthcare services to pregnant women seeking ANC
services. Sample size was determined based on similar
qualitative assessments conducted among similar popu-
lations (Galloway et al. 2002). Healthcare workers were
included because of their integral role in counselling
and dispensing micronutrients to pregnant women
and their insight on structural influences such as the
availability and accessibility of these micronutrients at
the health-facility level. The study did not track utiliza-
tion of IFA supplements among pregnant women.
Instrumentation
A semi-structured interview guide, socio-demographic
survey, and consent form were developed in English
by the research team and translated to Shona by a pro-
fessional translator. The interview guide used with
pregnant participants had 15 open-ended questions
and additional probes, while the guide for interviews
with healthcare workers had 12 open-ended questions
and additional probes. An example of an interview
question for pregnant women was “What do you think
are the benefits of taking IFA tablets?”, while healthcare
workers were asked “What do you think are the ben-
efits of IFA supplementation to pregnant women?”
The socio-demographic survey was completed imme-
diately prior to each interview, and questions included
age, gender, race, marital status, maternal history and
profession. The consent form highlighted the study’s
purpose and emphasized voluntary participation.
Data collection
Data were collected by the first author and a trained
research assistant using a semi-structured interview
guide and socio-demographic survey delivered in either
English or Shona. Interviews lasted 30–45min. Prior to
data collection, interview questions were pretested with
three pregnant women and two healthcare workers
residing outside the study sites, and interview questions
were refined for comprehension (Willis 2005). Detailed
field notes were taken during and immediately follow-
ing the interviews. Study participants were recruited
from study maternity clinic waiting rooms using reac-
tive (e.g. fliers) and proactive (e.g. snowball and
in-person) recruitment strategies. Participants provided
signed consent and completed a brief interviewer-
administered socio-demographic survey immediately
prior to each interview. Interviews were conducted
between June and July 2014. All study participants
received a US$5 incentive for participating.
Ethical considerations
Approval was sought and received from the University
of South Carolina Institutional Review Board, City of
Harare Ethics Committee, and the Medical Research
Council of Zimbabwe (MRCZ). Participants were
assigned an ID number and no names linking partici-
pants to data were recorded. Study results were pre-
sented to community members, study clinics, the City
of Harare and the MRCZ through presentations and
written reports.
Data analysis
Interviews were audio recorded, transcribed verbatim
and translated by the principal investigator and a profes-
sional translator. The transcribed interviews and field
notes were analysed thematically using NVivo 10 (QSR
International, Melbourne, Australia) (Saldaña 2013).
Emergent coding of interview transcripts was conducted
to develop a preliminary code book (Saldaña 2013). The
code bookwas reviewed by two research teammembers,
Influences on utilization of IFA supplementation 3
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and further emergent coding was conducted until a
final code book was developed after saturation was
reached. Univariate analyses were conducted for
socio-demographic data using SAS 9.3 (SAS Institute,
Cary, North Carolina, USA).
We used interviewer triangulation to offset threats to
validity inherent in using a single interviewer (Maxwell
2013). The triangulation validation strategy was also
employed by using multiple data analysts to review
the data.
Results
Study results are presented according to sample character-
istics, individual experiences with IFA supplements,
knowledgeof IFAsupplementationand thehealth-service
and social environment on IFA supplementation utiliza-
tion. Participant quotes are identified by participant type
(i.e. pregnant woman or healthcare worker) and age.
Sample characteristics
The mean age of pregnant women was 26 years (range
18–36 years), and most were of Shona ethnicity
(95.8%). Most women were in married monogamous
relationships (87.5%) and had a high school education
between Form 1 and 4 (91.7%), half were Christian
Protestant, two-thirds were dependent on their partner
for income and three-quarters had a previous preg-
nancy. The average gestational age at initial ANC visit
was 6months, while the average gestational age at time
of interview was 8months (Table 1).
Healthcare workers had a mean age of 45 years
(range 32–54years) and were predominantly women
(92.9%). Healthcare worker positions were registered
nurse and midwife (42.9%), midwife (50.0%) and
state-certified nurse (7.1%) who had held their
positions for on average 13years (Table 2).
Individual experiences with iron and folic acid
supplements
Most pregnant women in this study liked the size of the
IFA tablet and were happy that it was one combination
pill as opposed to two separate pills. Most did not
mention anything negative about the taste or smell of
the tablets.
Forgetting to take iron and folic acid
A reason for non-utilization among some pregnant
women was forgetting to take the tablets. A pregnant
woman explained, “Sometimes, I forget. I want to take
themevery day, but sometimes I go towork at night so I
forget” (Pregnant woman, 31years).
Side effects
Most pregnant women reported experiencing side
effects, which had mostly negative implications on utili-
zation of IFA supplementation. Side effects included
Table 1. Socio-demographic characteristics of IFA supplementation
study participants: pregnant women (n= 24)
Pregnant women (n = 24)
Characteristics n (%)
Age
Mean age (years) 26
Age range (years) 18–36
Race
Black 24 (100)
Ethnicity
Shona 23 (95.8)
Ndebele 1 (4.2)
Marital status
Married monogamous 21 (87.5)
Married polygamous 3 (12.5)
Highest education level
High school (Form 1–4) 22 (91.7)
High school (Form 5–6) 2 (8.3)
Religious affiliation
Apostolic 7 (29.2)
Catholic 2 (8.3)
Protestant 12 (50.0)
Pentecostal 3 (12.5)
Main source of income
Formally employed 2 (8.3)
Self-employed 2 (8.3)
Cross border trading 2 (8.3)
Dependent on partner 16 (66.7)
None 2 (8.3)
Prior pregnancies (including miscarriages and stillbirths)
Yes 18 (75.0)
No 6 (25.0)
Average months pregnant at first ANC visit and at first
receipt of IFA
6
Average months pregnant at time of interview 8
Self-report measures for all SES data. Form 1–4 equivalent to the first
four grades of high school (ages 11–16 years). Form 5–6 equivalent to
the last two grades of high school (ages 16–18 years). ANC, antenatal
care; IFA, iron and folic acid.
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nausea, vomiting, constipation, blackened stool, and
dark urine. Although less commonly stated, increase
and decrease in appetite were also described as reasons
for not adhering to the IFA regimen with a pregnant
woman stating, “If I don’t feel like eating that day I
don’t take them because they make me feel hungry”
(Pregnant woman, 25years). Another pregnant woman
described, “If I take them in the morning, I spend the
whole day without appetite and wanting to vomit”
(Pregnant woman, 23years).
The side effects could be compounded by comorbid-
ities such as HIV/AIDS, with a healthcare worker
describing:
So we have cases of women who are HIV positive and they
are already taking tablets for that and those tablets have
their own side effects. So to add additional side effects
because they are taking these (IFA) tablets for the most
part, they may not want to take them. (Healthcare worker,
54 years)
Knowledge of iron and folic acid supplementation
Blood-enhancing tablets
The IFA tablets described by participants were dark red
in colour and contained ferrous fumarate (182.4mg,
equivalent to 60mg of elemental iron) and 0.46mg of
folic acid. Tablets were introduced to pregnant women
during their first ANC visit, and each pregnant woman
received the tablets in a clear packet containing 30
tablets labelled with the tablet name and dosage. The
common dosage was one tablet daily until delivery
and pregnant women could refill their tablets at each
subsequent ANC visit. If pregnant women tested posi-
tively for iron-deficiency or anaemia, a test that was
available in these clinics, they were given a higher dos-
age of two to three tablets daily or they were referred
to a local hospital for further testing. At the time of
the interviews, healthcare workers reported that IFA
supplements were fully stocked in both study clinics.
Participants described iron deficiency anaemia as
having ‘low blood’ and the IFA supplements as
‘blood-enhancing tablets’. Folic acid was encompassed
in this definition, and there was no local name to
describe folic acid. Participants associated IFA tablets
with their ability to increase blood while enhancing it
with nutrients.
Misconceptions
Misconceptions about IFA supplementation contrib-
uted to non-utilization, and stemmed from lack of un-
derstanding about the components and effects of the
supplements. When asked, most pregnant women did
not know that folic acid was in IFA tablets, and none
knew its purpose. They said that the healthcare worker
did not talk about folic acid or that they could not
remember them talking about folic acid. A pregnant
women said, “We were just told to take these tablets.
They are blood-enhancing tablets, once per day. They
did not explain a lot” (Pregnant woman, 22years).
Although all healthcare workers were knowledge-
able about IFA supplementation, they acknowledged
that they did not describe the purpose of folic acid to
the pregnant women stating, “In most cases we do not
explain. We just take them as one and the same
thing…they are blood-enhancing tablets; and it will
end like that. It is very rare for us to distinguish
between ferrous sulphate and folic acid” (Healthcare
worker, 46 years). Another healthcare worker
explained, “We do describe and tell them the contents
of the tablet, but sometimes it’s a bit difficult to really
explain it in Shona. If you want to explain it in English,
Table 2. Socio-demographic characteristics of IFA supplementation
study participants: healthcare workers (n= 14)
Healthcare workers (n = 14)
Characteristics n (%)
Age
Mean age (years) 45
Age range (years) 32–54
Gender
Male 1 (7.1)
Female 13 (92.9)
Race
Black 14 (100)
Ethnicity
Shona 14 (100)
Position
Registered nurse and midwife 6 (42.9)
Midwife 7 (50.0)
State certified nurse 1 (7.1)
Number of years in position
Average 13
Range 1.5–26
IFA, iron and folic acid.
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sometimes our community won’t be able to understand
it” (Healthcare worker, 32 years).
Misconceptions arose about the type of medication
the pregnant women were taking. A healthcare worker
explained:
Someone actually asked me, “Nurse, you said these are
blood-enhancing tablets, are people at home supposed to
know about this? Because those people on antiretroviral
drugs also take these tablets, is it not the case that if people
see me taking these tablets they will assume that I also take
antiretroviral drugs?” The point is that a person will not
take them; she would just put them aside or even throw
them away because they are afraid of the people they live
with such as aunts and in-laws. They might think the tablets
are antiretroviral drugs. (Healthcare worker, 46 years)
Pregnant women were worried about people think-
ing that they were taking HIV medications, so they
would take their IFA tablets in secret or stop taking
them altogether.
Healthcare workers believed that pregnant women
did not understand the possible effects of taking the
tablets, which led them to associate the negative side
effects with the supplements being ineffective. A
healthcare worker explained, “Their perception is like
they don’t fully believe in the iron tablet because they
think it causes problems for them once they are consti-
pated or once they start passing the darkened stool”
(Healthcare worker, 50 years).
Limited access to nutrition information
Most pregnant women reported not having an avenue
through which they received nutrition information.
Some pregnant women described receiving nutrition
information at the clinic from nurses or reading charts
posted on clinic walls. A pregnant woman reported
receiving nutrition information from her husband
stating, “I do not go anywhere but I rely (on) my
husband (who) brings me pamphlets about nutrition
for pregnant women from his work place” (Pregnant
woman, 23 years). Some pregnant women did not
receive nutrition information when they came for
ANC with a pregnant woman stating, “They did not
talk about diet” (Pregnant woman, 27years).
Pregnant women who reported receiving nutrition
information during ANC described iron-rich foods that
they said were beneficial for women with low blood
that included dark leafy vegetables, chicken livers and
root vegetables.Apregnantwomandescribed healthcare
workers telling her, “You should eat a balanced diet,
mostly green leafy vegetables, liver and potatoes,
sweet potatoes, carrots and drink a lot of water”
(Pregnant woman, 25 years).
Contrary to pregnant women’s descriptions, all
healthcare workers described providing nutrition
information to pregnant women during ANC, with a
healthcare worker stating:
We also should encourage our women to consider their diet
seriously because it cannot be the tablets alone that are
important…her diet should also be rich in iron. However,
because some would not know about it, they will concen-
trate on taking blood-enhancing tablets without considering
the issue of diet. (Healthcare worker, 43 years)
Healthcare workers described that one reason they
shared information about iron-rich foods to eat during
pregnancy was because pregnant womenwere consum-
ing white sand or ‘daga’, which is usually found on
trees, and some pregnant women associated this white
sand consumption with iron deficiency. A healthcare
worker stated:
Some of them want to eat daga…Someone was saying that
that is a sign of iron deficiency.We tried to tell them to leave
the daga because it causes constipation…and you don’t
knowwhere it comes from…We try to tell them about a diet
to eat pumpkin leaves, spinach, liver so that it helps them
boost their iron levels and also it will keep them healthy.
(Healthcare worker, 39 years)
A healthcare worker described that at times they
handed out nutrition-related print materials, but they
were out of stock. They did not have nutrition print
materials specific to IFA supplementation.When asked
about distributing nutrition print materials to pregnant
women attending ANC, a healthcare worker acknowl-
edged, “Yeah at times we do that is if we have them.
And we also have posters for them so that when they
are sitting they can read about diet, immunization and
everything, but for iron and folic acid, I have not seen
them” (Healthcare worker, 39 years).
Risks and benefits of supplementation
Knowledge of risks and benefits of supplementation
influenced most pregnant women to adhere to their
6 C. B. Tinago et al.
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IFA supplementation regimen. A pregnant woman
explained:
The other issue is that we should be given enough
information; like whether or not we should take them
before or after eating…If you have the information you will
persevere because with anything good, there are side
effects…I want him/her (healthcare worker) to tell me their
exact function in my body and their importance to me and
my child as well as the way I should take them. (Pregnant
woman, 23 years)
Most pregnant women explained that healthcare
workers described the benefits and side effects of
taking the IFA tablets. The benefits described in-
cluded increased blood, reduced risk of negative
effects with blood loss at delivery, increased
strength, reduced craving for white sand (daga)
and health of mother and baby. Side effects that
the pregnant women described the healthcare
worker explaining included blackened stool, dark
urine, nausea and vomiting.
Healthcare workers described the benefits of taking
the IFA tablets that they shared with pregnant women,
which included increased blood, lower possibility of
post-partum haemorrhage and for the baby’s health.
A healthcare worker stated:
We tell them that now they are two so the mother needs
more blood to be able to take care of the baby as well and
when they deliver most likely they will lose a lot of blood
so we will be trying to make sure that they have a lot of
blood to begin with for delivery and for the baby.
(Healthcare worker, 39 years)
The side effects that healthcare workers de-
scribed sharing with pregnant women included
blackened stool, dark urine, constipation, nausea
and vomiting. Healthcare workers stated that they
encouraged pregnant women to take their tablets
with food to counter side effects stating, “To avoid
nausea, they should take the tablet with food. The
tablets cause nausea, so in most cases it is better if
you take them whilst eating sadza (maize staple
food)” (Healthcare worker, 38 years). Healthcare
workers emphasized that the pregnant women
should take their IFA tablets at the same time
every day and drink lots of fluids to counter side
effects such as constipation.
Fear of negative health complications with non-utilization
Most pregnant women described fear of losing blood
during delivery as a driving force for taking IFA tablets
as prescribed. A pregnant woman stated, “I take the
tablets because I am scared that when I deliver and I
lose a lot of blood and I wasn’t taking my tablets I
may not be strong enough” (Pregnant woman,
22 years). Some pregnant women highlighted that
excessive bleeding at delivery brings about an added
cost for a blood transfusion, with a pregnant woman
describing, “I take them so that when I deliver, I will
not lose a lot of blood because buying the blood will
be expensive” (Pregnant woman, 28 years).
Shared blood between mother and fetus and health
of the fetus were a common response as to why preg-
nant women were utilizing the IFA supplements, with
a pregnant woman describing, “I was just told that the
fetus uses that blood, so you would think that the fetus
would be in trouble if there is a shortage. I am afraid of
that…you will be thinking about your child and this
encourages you to take them properly” (Pregnant
woman, 22 years).
Health-service and the social environment on iron
and folic acid supplementation utilization
Influences on IFA supplementation utilization were
found at the structural level with delayed entry or
non-uptake of ANC services and social environment
influences. The following is a detailed description of
these influences.
Delayed entry or non-uptake of antenatal care services
All pregnant women described their introduction to
IFA supplementation occurring at their initial ANC
visit, which is termed a booking in this context. The
majority of pregnant women described attending their
initial ANC visit at between 5 and 6months pregnant.
Healthcare workers emphasized the need to educate
pregnant women about attending their initial ANC visit
earlier in their pregnancy for IFA supplementation
effectiveness with a healthcare worker explaining:
These women need to be educated that they should book
early because if they book early…maybe they will be able
to start the folic at an earlier stage…You find, I don’t know
Influences on utilization of IFA supplementation 7
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whether it is our culture or not, or maybe it’s because of so-
cioeconomic problems, you find someone books at
38weeks, next week delivers, or maybe we will have given
them a packet for 28 days obviously most of the time they
do not finish. (Healthcare worker, 39 years)
The healthcare workers discussed the high number
of women who deliver babies in the clinic without at-
tending an ANC visit. A healthcare worker explained:
What we see is we have a lot of unbooked cases so those
unbooked cases at times they give us problems or it’s an
unbooked and they deliver at home…Maybe she bled a
lot…When we see her she will have anemia because of the
bleeding that occurred. I think people should be educated
that they need to deliver at clinics… because when BBA
(born before arrival) occurs, we cannot account for it
because it occurred at home. (Healthcare worker, 39 years)
These unbooked deliveries and ‘born before arrival’
cases mean that pregnant women probably have not
received IFA supplements because all women in the
study were introduced to the supplements during their
initial ANC visit.
Healthcare worker recommendation for iron and folic acid
supplementation
A common response from most pregnant women
concerning why they took their IFA tablets was
healthcare worker recommendation. The pregnant
women valued the opinions of the healthcare workers
and affectionately called them ‘grandmother’ and
‘grandfather’. A pregnant woman said, “They told me
and I follow instructions…they know what they will
be doing” (Pregnant woman, 36years). Another added,
“The blood-enhancing tablets I take them because they
are good in that they make it so that we have enough
blood in our body since this is what the healthcare
worker said. Also, what is promoted at the clinic are
things that are good” (Pregnant woman, 30years).
Social norms among pregnant women
Most pregnant women acknowledged thatmost of what
they heard from ‘other’ pregnant and previously preg-
nant womenwere negative comments about side effects
and tablets not functioning as prescribed. A pregnant
woman described, “Most people that I talk to have
problems with the tablets; people do not like them
and they do not take them even when they receive
them…they say, “I lose appetite when I take them”. I
hear many people saying that” (Pregnant woman,
23years). Healthcare workers identified how ‘others’
mostly negatively influenced pregnant women’s utiliza-
tion of IFA supplementation. A healthcare worker
described:
The problem is that we teach them, but they have their own
teachers. There are those who have delivered a long time
ago and they say, “Do not take them, they do not help with
anything”. Or some will say, “I took them and they make
me vomit”. Then by the end of the day they don’t take the
tablets. So it’s their conversations with others which disrupt
our efforts. (Healthcare worker, 54 years)
Social support from family members
Views and support from husbands, mothers, mothers-
in-law, sisters and other family and friends were impor-
tant in most pregnant women utilizing and adhering to
IFA supplementation. Pregnant women spoke about
how ‘others’ positively influenced their utilization of
IFA supplementation with a pregnant woman stating:
My husband. He is the one who is strict when it comes to
tablets. When I told him that they are blood-enhancing
tablets, he said it is a must that I take them because I have
a problem of low blood in the body… My mother-in-law
actually encourages me. She argues that I should get more
(tablets) if it is possible. (Pregnant woman, 22 years)
Healthcare workers described needing to educate
the community about IFA because they also influence
pregnant women’s beliefs and attitudes concerning
the supplements. Healthcare workers described a
community that includes partners, aunts, friends,
community leaders, mothers and mothers-in-law. The
community could then advocate to encourage uptake
and utilization of IFA among pregnant women. A
healthcare worker stated:
What I see and believe in, is that knowledge is the important
thing. If all of them know why they are taking tablets,
including aunts, it leads to a great improvement on tablet
uptake. However, the information is too little for them to
have it, especially when they are at home. The aunts may
not have the information…they would think that she is on
ART (antiretroviral therapy). So, if the aunts have that
knowledge beforehand they will actually encourage the
pregnant women to take the tablets. Maybe information
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dissemination is what is needed.Maybe the information can
be aired on radio or television for aunts to know…men
should participate in it, and they should be informed that
their wives will be taking blood-enhancing tablets.
(Healthcare worker, 43 years)
Discussion
Utilization of IFA supplementation by pregnant
women in Harare was grounded in experiences with
and knowledge of IFA supplements and the health-
service and social environment. Reasons for low utiliza-
tion included forgetting to take IFA, side effects,
misconceptions about IFA supplementation, limited
access to nutrition information, delayed entry or
non-uptake of ANC services and social norms of
pregnant women for IFA supplementation. Utilization
was enhanced by knowledge of risks and benefits of
supplementation, fear of negative health complications
with non-utilization, family support and healthcare
worker recommendation for IFA supplementation.
Studies conducted in other developing countries identi-
fied both similar and different reasons for utilization,
with low utilization resulting from inadequate supply
of micronutrients, lack of knowledge, side effects and
difficult access and underutilization of ANC services,
while utilization was enhanced by improved health for
mother and baby, less fatigue, and improved appetite
(Galloway &McGuire 1994; Galloway et al. 2002; Seck
& Jackson 2008; Nisar et al. 2014).
The influence that the health-services and social
environment has on utilization of IFA supplementa-
tion emphasizes the need to engage aspects of the
structural environment that go beyond the individual
to improve utilization of IFA supplementation
(Cohen et al. 2000). For example, ANC was a key
influencer in IFA supplementation uptake and utiliza-
tion because this was where women received the sup-
plements. If pregnant women do not attend ANC or
delay the initial or subsequent ANC visits, they are
less likely to take or adhere to IFA supplementation.
In Zimbabwe, the median months pregnant at initial
ANC visit is 5.3months, and the pregnant women in
our study reported attending their initial ANC visit
on average at 6months (ZDHS 2012). Considering
that IFA supplements are more effective when taken
throughout the duration of pregnancy, addressing
uptake and attendance at ANC is an important way
to improve utilization of IFA supplementation, in
addition to extending IFA supplementation to those
not attending ANC.
On a family level, husband support for supplementa-
tion was identified as positively influencing utilization,
which was also a finding in Nigeria where husband
support improved women’s motivation to adhere to
iron supplementation (Ejidokun 2000). On a commu-
nity level, a systematic review of social determinants
of iron supplementation amongwomen of reproductive
age conducted by Nagata and colleagues (2012) identi-
fied the importance of community mobilization, com-
munity organizations such as women’s groups and
social networks in iron supplementation utilization,
and emphasized involving and sensitizing these groups
to increase support for supplementation. Including
pregnant women’s social networks in community-based
efforts to improve IFA supplementation has potential
to increase utilization of IFA supplementation among
this population.
Individual influences on IFA utilization identified in
this study such as misconceptions concerning IFA sup-
plementation and limited nutrition knowledge highlight
the need for approaches that bridge the knowledge gap
around IFA supplementation. These approaches
should begin pre-pregnancy in the time before a
woman contemplates or becomes pregnant (Whitworth
& Dowswell 2009; Bhutta et al. 2013). This is especially
important in countries like Zimbabwe where there is
low or late utilization of ANC services which this study
identified as the main source of education on and distri-
bution of IFA supplements. We need to provide and
improve nutrition programming targeting pregnant
and non-pregnant women in developing countries like
Zimbabwe in addition to extending this education to
members of their social networks who could potentially
aid in pregnant women not forgetting to take IFA. We
also need to explore how IFA supplementation affects
pregnant women with HIV. Although availability of
IFA supplements was not identified as an influence on
IFA utilization, it still needs to be addressed because
there were stock-outs of supplements in one of the
study clinics during another study we conducted the
following year.
Influences on utilization of IFA supplementation 9
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Strengths of this study include the use of in-depth in-
terviews and the inclusion of healthcare workers in the
study sample. Study limitations include interviewing
neither pregnant women not seeking ANC services
nor family members. Although our results cannot be
generalized to all pregnant women inHarare, this study
is an important step in assessing and documenting
perspectives on utilization of IFA supplementation in
pregnancy.
Conclusion
This study advances understanding of utilization of IFA
supplementation among pregnant women in
Zimbabwe, and highlights needs to strengthen efforts
to improve maternal micronutrient status. Future
approaches to improve maternal IFA supplementation
utilization in Zimbabwe should address individual and
structural environmental factors that begin before and
continue throughout pregnancy. These approaches
should reach those not currently seeking ANC with
the long-term goal of reducing maternal and child
morbidity and mortality related to micronutrient
deficiencies.
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